Manuel Fernández-Navarro

Immunogenicity and reactogenicity of a third dose of BNT162b2 vaccine for COVID-19 after a primary regimen with BBIBP-CorV or BNT162b2 vaccines in Lima, Peru

L. Solari, J. Silva-Valencia, R. Araujo-Castillo, 2022, medRxiv.

Effectiveness of the BBIBP-CorV vaccine in preventing infection and death in health care workers in Peru 2021

L. Solari, P. Mayta-Tristán, J. Silva-Valencia, 2021, Travel Medicine and Infectious Disease.

Evaluation of the humoral response induced by BBIBP-CorV vaccine by determining neutralizing antibodies in peruvian healthcare personnel.

A. Soto, Manuel Fernández-Navarro, Flor de María Charca-Rodríguez, 2021, Revista peruana de medicina experimental y salud publica.

I g G antibody response by ELISA using Wuhan and Lambda variant antigens in BBIBP-CORV vaccinated health care workers

L. Solari, L. Pampa-Espinoza, M. Huaringa-Núñez, 2022 .

Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 Reinfections After a Second Wave With Predominance of Lambda in Lima and Callao, Peru

L. Solari, O. Cáceres, M. Galarza, 2022, Open forum infectious diseases.

IgG antibody response by ELISA using Wuhan and Lambda variant antigens in BBIBP-CORV vaccinated health care workers.

L. Solari, Lely Solari, L. Pampa-Espinoza, 2022, Revista peruana de medicina experimental y salud publica.